ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 78024 | ISO 21474-2:2022 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification | Standarts spēkā |
| 85349 | ISO 18704:2026 | Molecular in vitro diagnostic examinations — Requirements and recommendations for pre-examination processes for urine and other body fluids — Isolated cell-free DNA | Standarts spēkā |
| 70960 | ISO 21474-1:2020 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 1: Terminology and general requirements for nucleic acid quality evaluation | Standarts spēkā |
| 42022 | ISO 15194:2009 | In vitro diagnostic medical devices — Measurement of quantities in samples of biological origin — Requirements for certified reference materials and the content of supporting documentation | Standarts spēkā |
| 72191 | ISO 15190:2020 | Medical laboratories — Requirements for safety | Standarts spēkā |
| 77070 | ISO/TS 23824:2024 | Medical laboratories — Guidance on application of ISO 15189 in anatomic pathology | Standarts spēkā |
| 79379 | ISO 16256:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases | Standarts spēkā |
| 54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
| 71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
| 72141 | ISO/TS 16782:2016 | Clinical laboratory testing — Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing | Standarts spēkā |
Displaying 121-130 of 146 results.